27
Participants
Start Date
October 16, 2017
Primary Completion Date
July 27, 2018
Study Completion Date
July 27, 2018
FLX-787-ODT (orally disintegrating tablet)
FLX-787-ODT taken three times daily for 28 days
Placebo ODT
Placebo ODT taken three times daily for 28 days
Columbia University Medical Center, New York
University of Rochester Medical Center, Rochester
Penn State Milton S. Hershey Medical Center, Hershey
Temple University, Philadelphia
Mayo Clinic, Jacksonville
University of Florida, Gainesville
University of South Florida, Tampa
University of Iowa, Iowa City
University of Minnesota, Minneapolis
Saint Louis University, St Louis
University of Kansas Medical Center, Kansas City
University of Colorado, Aurora
The University of Utah, Salt Lake City
Mayo Clinic, Scottsdale
Oregon Health Science University, Portland
Saint Luke's Rehabilitation Institute, Spokane
Hospital for Special Care, New Britain
Massachusetts General Hospital, Boston
Brighman and Women's Hospital, Boston
University of Vermont Medical Center, Burlington
Lead Sponsor
Flex Pharma, Inc.
INDUSTRY